4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001797917-26-000009
Director sold 574 shares at $9.79 ($5,619)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prener Anne Director | 2026-11-12 | Sale 10b5-1 | −574 | $9.79 | $5,619 | 13,212 | D: show line 1 in the form |
| Open-market sales · 574 sh · avg $9.79 · $5,619 | |||||||
Loading xslF345X06/form4-11162026_041102.xml…